The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse Non-interventional study to assess reaching of cholesterol target values in patients treated with HMG-CoA reductase inhibitors in Croatia
- collapse An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia
- collapse A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD6714 in Healthy Male Volunteers and Male Type II Diabetic Patients
- collapse An Open-Label, Randomised, Placebo-Controlled, Two-Way Crossover, Phase I Single Centre Study in Type 2 Diabetes Mellitus Patients Treated with Metformin to Evaluate the Pharmacokinetics and Pharmacodynamics of Warfarin During Co-administration with AZD1656
- collapse A Randomised, open, two-way Cross-over, Phase I Study to Evaluate the Response to Glucagon versus the spontaneous counter-regulatory response in T2DM Patients treated with AZD1656 and Metformin during hypoglycemia
- collapse A Phase I, Multi-center, Open-label, Single Dose Study, to Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients With or Without Renal Impairment
- collapse Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Fasting After Single Ascending Oral Doses of AZD5658 in Type 2 Diabetes Mellitus Patients
- collapse A randomized, single-blind, placebo-controlled, phase I study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD1656 compared to placebo in T2DM patients treated with metformin and sulfonylurea
- collapse A Randomised, Single-Blind, Placebo-Controlled, Phase IIA Study to Assess the Safety and Tolerability after Multiple Oral Doses of AZD1656 in Patients with Type 2 Diabetes Mellitus Treated with Metformin
- collapse A Randomised, Two Way Cross-over, Single-Blind, Phase I Study to Evaluate 24-hr Glucose Profiles in Patients with T2DM when Dosed OD and BD on Top of Metformin for Four Days with AZD1656
